Zurcher Kantonalbank (Zurich Cantonalbank) - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2021$0
-100.0%
1
-99.9%
0.00%
Q3 2021$13,000
-23.5%
1,8640.0%0.00%
Q2 2021$17,000
-64.6%
1,864
-62.0%
0.00%
Q1 2021$48,000
-4.0%
4,9040.0%0.00%
Q4 2020$50,000
+2.0%
4,9040.0%0.00%
Q3 2020$49,000
-3.9%
4,9040.0%0.00%
Q2 2020$51,000
+240.0%
4,904
+172.4%
0.00%
Q1 2020$15,000
-37.5%
1,800
-33.3%
0.00%
Q4 2019$24,000
-17.2%
2,6990.0%0.00%
Q3 2019$29,000
-14.7%
2,6990.0%0.00%
Q2 2019$34,000
-69.6%
2,699
-6.9%
0.00%
-100.0%
Q1 2019$112,000
+89.8%
2,8990.0%0.00%0.0%
Q4 2018$59,000
-55.6%
2,8990.0%0.00%0.0%
Q3 2018$133,000
-22.2%
2,8990.0%0.00%
-50.0%
Q2 2018$171,000
-13.2%
2,8990.0%0.00%0.0%
Q1 2018$197,000
-39.6%
2,899
-12.1%
0.00%
-33.3%
Q4 2017$326,000
+6.5%
3,299
+28.9%
0.00%0.0%
Q3 2017$306,000
+229.0%
2,559
+141.6%
0.00%
+200.0%
Q2 2017$93,000
+210.0%
1,059
+33.0%
0.00%
Q1 2017$30,000
+25.0%
7960.0%0.00%
Q4 2016$24,000
-54.7%
7960.0%0.00%
-100.0%
Q3 2016$53,000
+165.0%
796
+19.5%
0.00%
Q2 2016$20,0000.0%6660.0%0.00%
Q1 2016$20,000
-61.5%
6660.0%0.00%
-100.0%
Q4 2015$52,000
-64.6%
666
-66.0%
0.00%
-50.0%
Q3 2015$147,000
-35.5%
1,9570.0%0.00%
-33.3%
Q2 2015$228,000
+635.5%
1,957
+1405.4%
0.00%
Q1 2015$31,0001300.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,536,156$21,405,0002.24%
Palo Alto Investors LP 1,396,163$11,784,0000.99%
Camber Capital Management LP 1,950,000$16,458,0000.98%
TANG CAPITAL MANAGEMENT LLC 800,000$6,752,0000.95%
Capital Impact Advisors, LLC 147,303$1,243,0000.52%
Sofinnova Investments, Inc. 638,026$5,385,0000.50%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 963,212$8,130,0000.26%
RICE HALL JAMES & ASSOCIATES, LLC 466,482$3,937,0000.22%
PDT Partners, LLC 204,238$1,724,0000.14%
Eversept Partners, LP 58,251$491,6380.12%
View complete list of PUMA BIOTECHNOLOGY INC shareholders